Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIMERIX LIMITED Board/Management Information 2009

Sep 1, 2009

64804_rns_2009-09-01_a4cce90e-fd6d-4146-aa80-5056de42bb12.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [227 x 84] intentionally omitted <==

ASX Company Announcement

Changes to Director Appointments

2 September 2009

Sun Biomedical Limited (ASX Code: SBN) wishes to advise that Mr. Terry Cuthbertson has joined the Board as a Non-Executive Director and Chairman-elect. Mr. Terry Cuthbertson will replace Mr. Peter King as the Chairman of the Board of Directors in the near future. Mr. Peter King will remain as a NonExecutive Director. In addition, Mr. Andrew Paice has resigned as a Non-Executive Director.

Mr. Cuthbertson is currently Chairman of Montec International Limited, Austpac Resources N.L., My Net Fone Limited and S2 Net Limited. He was also a partner of KPMG Corporate Finance and NSW Partner in Charge of Mergers and Acquisitions where he coordinated government privatization, mergers, acquisitions and divesture activities and public offerings on the Australian Stock Exchange for the NSW practice. Prior to this, he was the Group Finance Director of Tech Pacific Holding Limited, which was the one of the largest information technology distributors in Asia with a turnover in 1999 of AUS2 billion and was a Director for Tech Pacific Limited‘s businesses in China, Hong Kong, Singapore, India, Philippines, Indonesia and Thailand.

Mr. Cuthbertson broadens the skill base of the Board during a period where the company is seeking new investment opportunities and the Board welcomes his appointment.

The Company thanks Mr. Paice for his contribution and service and extends its best wishes for success in his future endeavors.

For further information in relation to this announcement or any aspects of SBN’s operations please contact:

Jim Hallam Director Mobile: 0414965442

Sun Biomedical Investor Communications Limited Computershare T: +61 1300 850 505 | F: +61 3 9473 2500 | ABN 18 001 285 230 E: [email protected]

ASX:SBN